Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

FDA approves Lucemyra to mitigate opioid withdrawal symptoms

May 17, 2018

New phase II proof-of-concept trial studies IXT-m200 in methamphetamine users

May 11, 2018

Researchers present nanoencapsulated hepatocyte enzymes to fight alcohol intoxication

May 11, 2018

FDA clears Pluristem's IND application for PLX-R18 to treat acute radiation syndrome

May 2, 2018

Accelerator Life Science Partners launches Proniras

April 30, 2018

Researchers present gene therapy for methamphetamine-induced inflammation

April 27, 2018

Pear Therapeutics and Sandoz sign agreement for prescription digital therapeutics

April 19, 2018

Opiant Pharmaceuticals receives grant to develop intranasal nalmefene

April 19, 2018

AntoXa Corporation obtains license from DRDC for plant-made PhD9 anti-ricin antibody

April 19, 2018

Humanetics obtains NIAID grant to support development of BIO-300 as a medical countermeasure

April 13, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...